文献速递主动脉疾病

无并发症B型主动脉夹层主动脉增长预测因素:ADSORB数据库分析

Predictors of aortic growth in uncomplicated type B aortic dissection from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) database.
PubMed 文献 · J Vasc Surg · 2016-11-19

基于ADSORB试验数据库,比较接受最佳药物治疗(BMT)的无并发症B型主动脉夹层患者中假腔增长与未增长者的差异,并分析TEVAR+BMT与BMT在假腔血栓形成及主动脉直径变化上的趋势。假腔起源血管数量是假腔增长的独立预测因素,年龄增长为主动脉直径增长负预测因素,TEVAR+BMT在近端段血栓形成和直径逆转上优于BMT。

要点

  • 假腔起源血管数量是假腔增长的独立预测因素(OR 22.1)。
  • 年龄增长是总主动脉直径增长的负预测因素(OR 0.902)。
  • TEVAR+BMT在近端段A、B完全血栓形成率80.6% vs BMT 9.5%。

核心结论

  • 假腔起源血管数量是无并发症B型主动脉夹层患者假腔增长的独立预测因素。
  • 年龄增长是总主动脉直径增长的负预测因素。
  • 该分析有助于识别高风险无并发症B型主动脉夹层患者,以决定TEVAR或密切随访。

研究设计与样本

  • 从ADSORB试验数据库中筛选有基线和1年随访动脉CT的BMT患者。
  • 比较假腔增长组(I组)与无假腔增长组(II组)。
  • 比较BMT与TEVAR+BMT在四个节段(距左锁骨下动脉0-10 cm、10-20 cm、20-30 cm、30-40 cm)的假腔血栓形成及直径变化。

主要发现

  • I组夹层长度显著长于II组(43.2 ± 4.9 cm vs 30.4 ± 8.8 cm;P = .002)。
  • 假腔起源血管数量是假腔增长的独立预测因素(OR 22.1;95%CI 1.01-481.5;P = .049)。
  • 年龄增长是总主动脉直径增长的负预测因素(OR 0.902;95%CI 0.813-1.00;P = .0502)。
  • 近端A、B段完全血栓形成率TEVAR+BMT组80.6% vs BMT组9.5%。
  • A、B段总 lumen 直径变化:TEVAR+BMT组-4.8 mm和-1.5 mm,BMT组+2.9 mm和+3.8 mm。

关键数值与推荐

  • 假腔增长独立预测因素:假腔起源血管数量(OR 22.1;95%CI 1.01-481.5;P = .049)。
  • 总主动脉直径增长负预测因素:年龄增长(OR 0.902;95%CI 0.813-1.00;P = .0502)。
  • 近端A、B段完全血栓形成率:TEVAR+BMT组80.6% vs BMT组9.5%。
  • A、B段血栓改善率:TEVAR+BMT组90.3% vs BMT组31.0%。
  • C、D段血栓改善率:TEVAR+BMT组74.1% vs BMT组20.6%。

临床怎么用

  • 假腔起源血管数量多的无并发症B型主动脉夹层患者假腔增长风险高,应考虑TEVAR或密切随访。
  • 年轻患者主动脉增长风险较高,需加强影像学监测。
  • TEVAR+BMT在近端段促进假腔血栓形成和主动脉直径逆转,优于单纯BMT。

局限性

  • 研究基于ADSORB试验数据库,样本量有限。
  • 仅纳入有基线和1年随访CT的BMT患者,可能存在选择偏倚。
  • 假腔增长预测因素的优势比置信区间宽,需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The high-risk patient cohort of uncomplicated type B aortic dissections (uTBADs) needs to be clarified. We compared uTBAD patients treated with best medical treatment (BMT), with and without aortic growth, from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) trial database. Furthermore, we looked for trends in outcome for aortic growth and remodeling after BMT and thoracic endovascular aortic repair (TEVAR) and BMT (TEVAR+BMT). METHODS: BMT patients with available baseline and a 1-year follow-up arterial computed tomography scan were identified. True lumen and false lumen diameter was assessed at baseline and at follow-up. Patients with false lumen growth (group I) and without false lumen growth (group II) were compared. Predictors of false lumen and total lumen (aortic) growth were identified. Lastly, BMT outcomes were compared with BMT+TEVAR for false lumen thrombosis and change in false lumen and total aortic diameter in four sections: 0 to 10 cm (A), 10 to 20 cm (B), 20 to 30 cm (C), and 30 to 40 cm (D) from the left subclavian artery. RESULTS: The dissection was significantly longer in group I than in group II (43.2 ± 4.9 cm vs 30.4 ± 8.8 cm; P = .002). The number of vessels originating from the false lumen at baseline was identified as an independent predictor of false lumen growth (odds ratio, 22.1; 95% confidence interval, 1.01-481.5; P = .049). Increasing age was a negative predictor of total aortic diameter growth (odds ratio, 0.902; 95% confidence interval, 0.813-1.00; P = .0502). The proximal sections A and B showed complete thrombosis in 80.6% in the BMT+TEVAR group compared with 9.5% in the BMT group. In these sections, changes from patent to partial or partial to complete thrombosis were observed in 90.3% of the TEVAR+BMT group vs 31.0% in the BMT group. In sections C and D, the change in thrombosis was 74.1% for the TEVAR+BMT group vs 20.6% for the BMT group. The false lumen diameter increase at section C was larger in the BMT group. Total lumen diameter decreased in sections A and B in the TEVAR+BMT group compared with an increase in the BMT group (-4.8 mm vs +2.9 mm, and -1.5 mm vs +3.8 mm, respectively). Sections C and D showed minimal and comparable expansion in both treatment groups. CONCLUSIONS: The new imaging analysis of the ADSORB trial patients identified the number of vessels originating from the false lumen as an independent predictor of false lumen growth in uTBAD patients. Increasing age was a negative predictor of aortic growth. Our analysis may help to identify which uTBAD patients are at higher risk and should receive TEVAR or be monitored closely during follow-up.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kamman AV, Brunkwall J, Verhoeven EL, et al. Predictors of aortic growth in uncomplicated type B aortic dissection from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) database. J Vasc Surg. 2016. PMID: 27876516. doi:10.1016/j.jvs.2016.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。